Abstract: The present invention provides an oral formulation for activation of autologous stem cell, comprising a stem cell activator encapsulated into a water-in-oil-in-water (W/O/W) multiple emulsion; wherein the stem cell activator induces autologous CD34+CD45+ hematopoietic stem cells (HSCs), wherein the stem cell activator is selected from the group consisting of granulocyte colony-stimulating factor (G-CSF), stem cell factor (SCF) and combination thereof. The W/O/W multiple emulsion protects the stem cell activator from stomach acid digestion, preserving its bioactivity during transport to the bone marrow (BM) via the Peyer's patches of the intestinal lymphatic system.

Abstract: The present invention is related to a method for risk detection, diagnosis, prognosis and monitoring of Alzheimer's disease (AD). The method comprises the steps of: (1) measuring the level of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in a sample from the subject, and (2) comparing the level of GAPDH in the sample with two or more AD reference levels of GAPDH.

Abstract: The present invention is related to a method for risk detection, diagnosis, prognosis and monitoring of Alzheimer's disease (AD). The method comprises the steps of: (1) measuring the level of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in a sample from the subject, and (2) comparing the level of GAPDH in the sample with two or more AD reference levels of GAPDH.

Abstract: The present invention provides comprehensive compositions for treating problems associated with hair graying and balding via the incorporation of: (i) the cell growth factor of HSCF to induce the migration of melanocyte stem cells and keratinocyte stem cells and then to increase the growth of melanocytes and keratinocytes in hair follicles, (ii) a formula of amino acids and vitamins to provide the nutritional factors for hair growth and pigmentation, and (iii) minoxidil to enhance the function of HSCF on hair re-growth. The compositions comprising at least one of (i), (ii) or (iii) are administered on skin and/or scalp through liposome in the follicular delivery systems, including penetration enhancers and suitable carrier bases. The compositions packaged in liposome in the follicular delivery systems in this invention has been proven to reach the dermis from the skin surface within 15-30 min.